Gracopa SRL
The score of Gracopa shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +81 % Total assets +26 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Gracopa's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 348,678 € | ||||
| Equity | 284,117 € | ||||
| Cash | 850,708 € | ||||
| EBITDA | 424,140 € | ||||
| Total assets | €3.96m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jul 2026
- Year ended 31 Dec 2024filed on 22 Jul 2025
- Year ended 31 Dec 2023filed on 13 Jul 2024
- Year ended 31 Dec 2022filed on 28 Jul 2023
- Year ended 31 Dec 2021filed on 28 Jul 2022
Gracopa's financial analysis
- Solvency7.2%sector median: 32.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Gracopa
Gracopa's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0479.314.810
- VAT number
- BE0479314810
- Peppol
- Registered · 0208:0479314810 · as of 08 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Jan 2003
- Registered office
- 1000 Brussels
- Latest accounts
- 2025 · filed on 29 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Gracopa (SRL) has been based in Brussels since 2003, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 348,678 € and equity of 284,117 €; its revenue is not published. Its solvency stands at 7.2%, below the median of its sector (32.3%).
Companies similar to Gracopa
Companies in the same business, of comparable size and area, outside its group.
- MiniMed Belgium Wholesale of pharmaceutical and medical goods Brussels · balance sheet 8,076 €
- Septodont NV-SA Wholesale of pharmaceutical and medical goods Ganshoren · balance sheet €4.33m
- Laboratoires Expanscience Belgium Wholesale of pharmaceutical and medical goods Asse · balance sheet €3.25m
- Michiels Wholesale of pharmaceutical and medical goods Brussels · balance sheet €5.00m
- Endoceutics Wholesale of pharmaceutical and medical goods Brussels · balance sheet €3.45m
- Launchpad Europe Wholesale of pharmaceutical and medical goods Oostkamp · balance sheet 120,635 €
- Maimonides Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 142 €
- Biocon Biologics Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €1.09m
Frequently asked questions about Gracopa
What is the revenue of Gracopa?
Gracopa files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Gracopa?
In Belgium, the VAT number is the company number prefixed with BE: BE0479314810 for Gracopa, if the company is VAT-registered. Its company number (CBE) is 0479.314.810.
Where is the registered office of Gracopa?
According to the CBE register, the registered office of Gracopa is in 1000 Brussels.
What is the equity of Gracopa?
At the close of the 2025 financial year, the equity of Gracopa amounts to 284,117 €, a solvency of 7.2% of total assets.
Who manages Gracopa?
The register lists 4 active mandates at Gracopa. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Gracopa
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →